Physician profile
Suzanne B Weber
NPI 1003914599
$17,568.36
in general payments reported to CMS, 2019-2025
25 companies · $2,125 in 2025
The $2,125 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $259 · 2021: $215 · 2022: $263 · 2023: $8,245 · 2024: $6,155 · 2025: $2,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $872 · Travel and Lodging: $133 · Consulting Fee: $50.00 · Education: $17.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,452.50 |
| Food and Beverage | $871.70 |
| Travel and Lodging | $133.20 |
| Consulting Fee | $50.00 |
| Education | $17.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $16,164.55 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $251.36 | 2019-2025 | |
| Baxter Healthcare | $153.23 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $132.58 | 2021-2023 | |
| Abbvie INC. | $88.44 | 2019-2023 | Liletta |
| Pfizer INC. | $85.61 | 2019-2023 | |
| Hologic Sales and Service, LLC | $82.20 | 2019-2023 | Acessa Provu System, Coolseal Generator, Omni Hysteroscope |
| Exeltis, USA INC. | $73.77 | 2019-2022 | |
| Organon LLC | $71.27 | 2021-2023 | Nexplanon |
| Avion Pharmaceuticals | $58.59 | 2020-2021 | |
| Myovant Sciences INC. | $49.34 | 2021-2022 | |
| Agile Therapeutics, INC. | $41.62 | 2021 | |
| Evofem Biosciences, INC. | $41.53 | 2021-2022 | |
| Therapeuticsmd, INC. | $39.99 | 2019 | |
| Medicem INC. | $34.00 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $31.89 | 2019 | |
| Coopersurgical, INC. | $30.24 | 2022-2023 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $29.80 | 2020 | |
| Coloplast Corp | $26.41 | 2022 | |
| Daiichi Sankyo INC. | $15.69 | 2019 | |
| Roche Diagnostics Corporation | $15.41 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.10 | 2019 | |
| Allergan, INC. | $12.51 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.45 | 2019 | |
| Lupin INC. | $11.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.